Restasis Is FDA-Approved, Allergan Reminds Compounder
Allergan USA Inc. on Wednesday urged a California federal court to shoot down false advertising counterclaims brought by drug compounder Imprimis Pharmaceuticals Inc., arguing that it's factually true that its dry-eye...To view the full article, register now.
Already a subscriber? Click here to view full article